Showing 9,621 - 9,640 results of 34,801 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 1.12s Refine Results
  1. 9621

    Effect of fenretinide and its metabolites on SCD expression and activity. by Eugenia Poliakov (116500)

    Published 2017
    “…<p>A) SCD1 protein expression is decreased after treatment with fenretinide, and its metabolite 3-keto-HPR. …”
  2. 9622
  3. 9623

    Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers by Viera Dobrotkova (6832433)

    Published 2019
    “…We found that the cell lines that were HMGA2-positive and/or HOXC9-negative have a reduced sensitivity to retinoids. Furthermore, the experiments revealed that the retinoid-sensitive cell lines showed a uniform pattern of change after treatment with both natural and sensitive retinoids: increased DDX39A and decreased PBX1 protein levels. …”
  4. 9624

    Modulation of Aβ-induced deleterious signaling. by Tao Yang (184280)

    Published 2008
    “…(H) In DIV 21–22 hippocampal neuronal cultures examined at the 3 hour time point, Aβ significantly decreased CREB phosphorylation by 43%, while this decrease was prevented by LM11A-24 and -31 (n = 10 separate Western blots from 5 independent protein preparations).…”
  5. 9625
  6. 9626

    Noise pollution limits metal bioaccumulation and growth rate in a filter feeder, the Pacific oyster <i>Magallana gigas</i> by Mohcine Charifi (4535101)

    Published 2018
    “…This latter conclusion points towards a potential risk in terms of ecosystem productivity.…”
  7. 9627

    Down-regulation of BjsR4 under tellurite and iron stresses, and impact of this down-regulation on survival at high iron concentration. by Julia Hahn (3279486)

    Published 2016
    “…<p><b>A)</b> The steady-state level of BjsR4 is decreased upon addition of tellurite. …”
  8. 9628
  9. 9629
  10. 9630
  11. 9631
  12. 9632

    RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity by Brandon L. Probst (727964)

    Published 2015
    “…Here, we characterized the in vitro antioxidant, anti-inflammatory, and anticancer activities of RTA 408, a novel AIM that is currently being evaluated in patients with advanced malignancies. …”
  13. 9633

    An Analysis of Porphyrin Molecular FlexibilityUse of Porphyrin Diacids by Beisong Cheng (2970567)

    Published 1997
    “…Molecular mechanics calculations, using a modified version of MM2(87) and a newly developed force field for porphyrin diacids, correctly predict that the flexibility of <i>meso</i>-tetraaryl porphyrin diacids decreases as the steric bulk of the peripheral substituents increases:  [H<sub>4</sub>TPyP]<sup>2+</sup> ≈ [H<sub>4</sub>TPP]<sup>2+</sup> > [H<sub>4</sub>T-2,6-(OH)<sub>2</sub> PP]<sup>2+</sup> ≈ [H<sub>4</sub>T-2,6-F<sub>2</sub> PP]<sup>2+</sup> > [H<sub>4</sub>T-2,6-Cl<sub>2</sub> PP]<sup>2+</sup> ≈ [H<sub>4</sub>TMP]<sup>2+</sup>. …”
  14. 9634

    Mean best-corrected visual acuity (BCVA) ± standard error of the means (± SEM) before and at 1, 2, 3, 4, 5 years and final visit following the LMT surgery. by Hisaaki Oshima (4042748)

    Published 2017
    “…<p>The BCVA was significantly improved at 1 year after surgery (<i>P</i> = 0.015), and the improved BCVA was maintained for at least 5 years after the surgery. In comparison with the preoperative BCVA, the BCVAs at all of the 3 postoperative time points (Year 1, Year 5, and the final examination) are improved by 2 or more lines of the visual acuity chart in 9 of the 20 eyes (45%), no change in 8 (40%), and decreased in 3 eyes (15%).…”
  15. 9635
  16. 9636
  17. 9637

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  18. 9638

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  19. 9639

    Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5‑<i>a</i>]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators by Shuai Wang (109515)

    Published 2020
    “…In this work, we reported the structure-based design of triazolo­[1,5-<i>a</i>]­pyrimidines as new ABCB1 modulators, of which <b>WS-691</b> significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC<sub>50</sub> = 22.02 nM). …”
  20. 9640

    Cell morphology varies among genetically distinct subgroups. by Laura K. Jackson (9922803)

    Published 2020
    “…<b>(D)</b> Subgroup 2B labeled with amino acid mutations in cell shape determining proteins (Csd4, Csd5, Csd6).</p>…”